Antibody biologics is a promising therapeutical area due to its high efficiency and low frequency of side effects. The advantages of this type of biologic stem from its ability to bind target molecules with high specificity and affinity. This marked efficacy has already been demonstrated in treatment of inflammatory diseases and cancers. Antibodies are also utilized in diagnosis and biomarker measurement, which can help to identify treatment options.
Our team is currently developing novel techniques for antibody generation and evaluation of antibodies bearing various characteristics. These techniques contribute to the discovery of antibody drugs that can potentially act on specific target activities of individual molecules. We are also focused on changes observed in protein modifications in specific diseases and pathologies, and on establishing antibodies that could detect or control their activities. Furthermore, we are attempting to develop drug delivery systems that would enable antibodies to act at specific times and sites within the body.